Literature DB >> 15816641

Pneumocystis carinii pneumonia in patients with solid tumors and lymphomas: predisposing factors and outcome.

Vassilios Barbounis1, George Aperis, Eleftherios Gambletsas, George Koumakis, Matina Demiris, Michael Vassilomanolakis, Anna Efremidis.   

Abstract

AIM: The incidence of Pneumonocystis carinii pneumonia (PCP) is increasing in patients with cancer. The possible routes of transmission in this population, as well as the epidemiological data of PCP, are not very well understood. The collection and analysis of data concerning the predisposing factors for PCP will elucidate this subject. PATIENTS AND METHODS: We studied 26 patients suffering from cancer who developed PCP during the five-year period 1997--2002.
RESULTS: Twenty-one patients had a solid tumor diagnosis while the remaining five had a lymphoma. All of them received intensive combination chemotherapy, while eight of them also received high-dose therapy and bone marrow transplantation. Nineteen of our patients had long hospitalization before the onset of PCP. All of them had received corticosteroids for various reasons. Among them, many patients had been exposed to radiotherapy and, in particular, in fields which encompass the major thoracic duct. Eighteen patients survived after the initiation of appropriate treatment, while eight others succumbed.
CONCLUSION: In this series, protracted deep lymphopenia, long hospitalization, radiotherapy and intensive chemotherapy were considered serious risk factors for developing PCP.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15816641

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  7 in total

1.  Influence of type of cancer and hematopoietic stem cell transplantation on clinical presentation of Pneumocystis jiroveci pneumonia in cancer patients.

Authors:  H A Torres; R F Chemaly; R Storey; E A Aguilera; G M Nogueras; A Safdar; K V I Rolston; I I Raad; D P Kontoyiannis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-06       Impact factor: 3.267

2.  Pneumocystis pneumonia in HIV-infected and immunocompromised non-HIV infected patients: a retrospective study of two centers in China.

Authors:  Fei Guo; Yong Chen; Shuang-Li Yang; Huan Xia; Xing-Wang Li; Zhao-Hui Tong
Journal:  PLoS One       Date:  2014-07-16       Impact factor: 3.240

3.  [Requirements for hygiene in the medical care of immunocompromised patients. Recommendations from the Committee for Hospital Hygiene and Infection Prevention at the Robert Koch Institute (RKI)].

Authors: 
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2010-04       Impact factor: 1.513

4.  Pneumocystis jirovecii Pneumonia in Three Patients With Breast Cancer Receiving Neoadjuvant Dose-Dense Chemotherapy.

Authors:  Ritsuya Shiiba; Daisuke Himeji; Ryoichi Matsumoto; Gen-Ichi Tanaka; Naoki Otomo
Journal:  Cureus       Date:  2022-02-01

5.  Pulmonary toxicity of craniospinal irradiation using helical tomotherapy.

Authors:  Joongyo Lee; Euidam Kim; Nalee Kim; Chang-Ok Suh; Yoonsun Chung; Hong In Yoon
Journal:  Sci Rep       Date:  2022-02-25       Impact factor: 4.379

6.  Pneumocystis carinii pneumonia in gastric cancer patients without acquired immune deficiency syndrome: 3 cases report and literature review.

Authors:  So Young Yoon; Hyun Kyun Ki; Sung Yong Kim; Yo Han Cho; Hong Ghi Lee; Moon-Won Yoo
Journal:  J Korean Surg Soc       Date:  2012-06-26

7.  Severe pneumocystis jiroveci pneumonia in a patient on temozolomide therapy: A case report and review of literature.

Authors:  Babar Ahmad Khan; Sania Khan; Benjamin White; Ambika Eranki
Journal:  Respir Med Case Rep       Date:  2017-08-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.